Eosinophil Cationic Protein Variation in Patients with Asthma and CRSwNP Treated with Dupilumab

Background: Asthma is a clinical syndrome characterized by recurrent episodes of airway obstruction, bronchial hyperresponsiveness and airway inflammation. Most patients with asthma present a “type 2” (TH2) inflammation. ILC2 and TH2 cells release cytokines IL4, IL-13 and IL-5. CRSwNP is a condition...

Full description

Bibliographic Details

Main Authors:	Andrea Giovanni Ledda, Giulia Costanzo, Giada Sambugaro, Cristiano Caruso, Martina Bullita, Maria Luisa Di Martino, Paolo Serra, Davide Firinu, Stefano Del Giacco
Format:	Artigo
Language:	Inglês
Published:	MDPI AG 2023-09-01
Series:	Life
Subjects:	asthma nasal polyps eosinophils cationic protein dupilumab biomarkers type 2 inflammation
Online Access:	https://www.mdpi.com/2075-1729/13/9/1884
Tags:	Add Tag No Tags, Be the first to tag this record!